2I-Iotamisligil G. Inflammation and metabolic disorders. Nature,2006,444(7121):860-867.
3Jeon YK,Kim MR,Huh JE,et al. Cystatin C as an early biomark- er of nephropathy in patients with type 2 diabetes[J]. J Korean Med Sci,2011,26(2) :258-263.
5Poege U,Stoschus B ,Stoffel wagner B ,et al. Cystatin C as an endogenous marker of glomerular fihration rate in renal transplant patients [J]. Kidney Blood Pressure Res ,2008,26( 1 ) : 55-60.